Tumor therapy in dogs with interleukin-releasing cell lines*
For the treatment of the majority of tumors diseases in dogs, only classical procedures by surgical removal of the tumor, radiation and chemotherapy are available, the development of new and patient-friendly therapy concepts is indispensable. A new therapeutic strategy provides for the use of biologically active canine interleukines ? especially interleukin-2 (cIL-2) and/or interleukin-12 (cIL-12). These canine interleukines are released by transfected BHK-Tet-on cells and transform in coculture natural killer cells (NK cells) isolated from the patient into lymphokine-activated killer cells (LAK cells), which are, transferred back into the patient, highly effective in the therapy of tumors.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…
